Pfizer, a global biopharmaceutical company headquartered in New York City, employs 88,000 people and focuses on discovering, developing, and distributing oncology, primary care, and specialty care products worldwide. Key products include Ibrance, Eliquis, and Xeljanz, among others.
PFE has been in the news recently: Pfizer Inc. has secured exclusive global rights to 3SBio Inc.'s SSGJ-707 bispecific antibody in a deal potentially worth up to $6 billion, excluding China. Additionally, Pfizer's shares are rising due to several positive developments in the market.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.